Publikation

Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration.

Wissenschaftlicher Artikel/Review - 14.10.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Altersberger V, Rusche N, Martinez-Majander N, Hametner C, Scheitz J, Hénon H, Dell'Acqua M, Strambo D, Stolp J, Heldner M, Grisendi I, Jovanovic D, Béjot Y, Pezzini A, Leker R, Kägi G, Wegener S, Cereda C, Lindgren E, Ntaios G, Piot I, Polymeris A, Lyrer P, Räty S, Sibolt G, Tiainen M, Heyse M, Erdur H, Kaaouana O, Padjen V, Zedde M, Arnold M, Nederkoorn P, Michel P, Bigliardi G, Zini A, Cordonnier C, Nolte C, Ringleb P, Curtze S, Engelter S, Gensicke H, Thrombolysis in Stroke Patients (TRISP) Collaborators. Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration. Stroke 2022; 53:3557-3563.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Stroke 2022; 53
Veröffentlichungsdatum
14.10.2022
eISSN (Online)
1524-4628
Seiten
3557-3563
Kurzbeschreibung/Zielsetzung

The probability to receive intravenous thrombolysis (IVT) for treatment of acute ischemic stroke declines with increasing age and is consequently the lowest in very elderly patients. Safety concerns likely influence individual IVT treatment decisions. Using data from a large IVT registry, we aimed to provide more evidence on safety of IVT in the very elderly.